Cargando…

ADXS11-001 immunotherapy targeting HPV-E7: final results from a Phase II study in Indian women with recurrent cervical cancer

Detalles Bibliográficos
Autores principales: Petit, Robert G, Mehta, Ajay, Jain, Minish, Gupta, Sudeep, Nagarkar, Rajnish, Kumar, Vijay, Premkumar, Sumana, Neve, Rakesh, John, Subhashini, Basu, Partha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288775/
http://dx.doi.org/10.1186/2051-1426-2-S3-P92
_version_ 1782352021767061504
author Petit, Robert G
Mehta, Ajay
Jain, Minish
Gupta, Sudeep
Nagarkar, Rajnish
Kumar, Vijay
Premkumar, Sumana
Neve, Rakesh
John, Subhashini
Basu, Partha
author_facet Petit, Robert G
Mehta, Ajay
Jain, Minish
Gupta, Sudeep
Nagarkar, Rajnish
Kumar, Vijay
Premkumar, Sumana
Neve, Rakesh
John, Subhashini
Basu, Partha
author_sort Petit, Robert G
collection PubMed
description
format Online
Article
Text
id pubmed-4288775
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42887752015-01-15 ADXS11-001 immunotherapy targeting HPV-E7: final results from a Phase II study in Indian women with recurrent cervical cancer Petit, Robert G Mehta, Ajay Jain, Minish Gupta, Sudeep Nagarkar, Rajnish Kumar, Vijay Premkumar, Sumana Neve, Rakesh John, Subhashini Basu, Partha J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4288775/ http://dx.doi.org/10.1186/2051-1426-2-S3-P92 Text en Copyright © 2014 Petit et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Petit, Robert G
Mehta, Ajay
Jain, Minish
Gupta, Sudeep
Nagarkar, Rajnish
Kumar, Vijay
Premkumar, Sumana
Neve, Rakesh
John, Subhashini
Basu, Partha
ADXS11-001 immunotherapy targeting HPV-E7: final results from a Phase II study in Indian women with recurrent cervical cancer
title ADXS11-001 immunotherapy targeting HPV-E7: final results from a Phase II study in Indian women with recurrent cervical cancer
title_full ADXS11-001 immunotherapy targeting HPV-E7: final results from a Phase II study in Indian women with recurrent cervical cancer
title_fullStr ADXS11-001 immunotherapy targeting HPV-E7: final results from a Phase II study in Indian women with recurrent cervical cancer
title_full_unstemmed ADXS11-001 immunotherapy targeting HPV-E7: final results from a Phase II study in Indian women with recurrent cervical cancer
title_short ADXS11-001 immunotherapy targeting HPV-E7: final results from a Phase II study in Indian women with recurrent cervical cancer
title_sort adxs11-001 immunotherapy targeting hpv-e7: final results from a phase ii study in indian women with recurrent cervical cancer
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288775/
http://dx.doi.org/10.1186/2051-1426-2-S3-P92
work_keys_str_mv AT petitrobertg adxs11001immunotherapytargetinghpve7finalresultsfromaphaseiistudyinindianwomenwithrecurrentcervicalcancer
AT mehtaajay adxs11001immunotherapytargetinghpve7finalresultsfromaphaseiistudyinindianwomenwithrecurrentcervicalcancer
AT jainminish adxs11001immunotherapytargetinghpve7finalresultsfromaphaseiistudyinindianwomenwithrecurrentcervicalcancer
AT guptasudeep adxs11001immunotherapytargetinghpve7finalresultsfromaphaseiistudyinindianwomenwithrecurrentcervicalcancer
AT nagarkarrajnish adxs11001immunotherapytargetinghpve7finalresultsfromaphaseiistudyinindianwomenwithrecurrentcervicalcancer
AT kumarvijay adxs11001immunotherapytargetinghpve7finalresultsfromaphaseiistudyinindianwomenwithrecurrentcervicalcancer
AT premkumarsumana adxs11001immunotherapytargetinghpve7finalresultsfromaphaseiistudyinindianwomenwithrecurrentcervicalcancer
AT neverakesh adxs11001immunotherapytargetinghpve7finalresultsfromaphaseiistudyinindianwomenwithrecurrentcervicalcancer
AT johnsubhashini adxs11001immunotherapytargetinghpve7finalresultsfromaphaseiistudyinindianwomenwithrecurrentcervicalcancer
AT basupartha adxs11001immunotherapytargetinghpve7finalresultsfromaphaseiistudyinindianwomenwithrecurrentcervicalcancer